FACT CHECK: Evaluating Claims That COVID-19 Vaccines Were Denied to White People Due to Race

A persistent political narrative claims that public health authorities in the United States systematically denied COVID-19 vaccines and life-saving therapeutics to white Americans based on their race.[4]

This assertion gained widespread traction following a January 2022 rally in Arizona, where former President Donald Trump declared that "if you're white, you don't get the vaccine, or if you're white, you don't get therapeutics."[1]

The claim has since been repeated in various forms, serving as a flashpoint in broader debates over medical equity, resource allocation, and civil rights.[4]

Evaluating the evidence requires separating the distribution of vaccines from the allocation of scarce antiviral treatments, as the two resources were governed by entirely different supply realities.[1][4]

Regarding vaccines, the claim is demonstrably false. By the time these statements were made, COVID-19 vaccines were in plentiful supply across the country, and no federal, state, or local policy ever restricted or rationed vaccine access based on a patient's race.[1]

The controversy surrounding therapeutics, however, is rooted in an actual public health policy, though the political framing heavily distorts how that policy was applied in practice.[1][4]

In late 2021, the emergence of the Omicron variant coincided with a severe national shortage of effective COVID-19 treatments, specifically monoclonal antibodies and oral antivirals like Paxlovid.[2]

To manage this scarcity, the New York State Department of Health issued a memo in December 2021 directing healthcare providers to prioritize these treatments for patients at the highest risk of severe illness or death.[2]

The triage guidance listed standard medical risk factors, including advanced age, cancer, diabetes, and compromised immune systems.[2]

However, the memo also included a footnote stating that "non-white race or Hispanic/Latino ethnicity should be considered a risk factor."[1][2]

The state's rationale was that "longstanding systemic health and social inequities" had contributed to a significantly increased risk of severe COVID-19 outcomes for minority populations.[1][2]

This inclusion of race as a triage metric was strongly supported by major public health organizations, including the American Medical Association (AMA).

Medical experts pointed to extensive data from the Centers for Disease Control and Prevention (CDC) and the National Institutes of Health (NIH), which showed that Black and Hispanic patients were hospitalized and died at rates roughly twice as high as white patients.[3]

The AMA argued that systemic inequities—such as disparities in housing density, employment exposure, and healthcare access—created a baseline risk for severe illness that was not fully captured by simply looking at a patient's age or individual medical chart.

Despite the medical rationale, the policy faced immediate legal and political pushback from critics who argued that using race as an independent risk factor was a violation of civil rights.

Lawsuits, such as Roberts v. Bassett filed by the Pacific Legal Foundation, challenged the guidance in federal court, arguing that it forced medical providers to prioritize healthy non-white patients over at-risk white patients.[2]

The plaintiffs asserted that a vaccinated, healthy minority patient could theoretically be placed ahead of an unvaccinated, elderly white patient with underlying conditions.[2]

In response to the backlash, New York health officials clarified that race was never used as a disqualifying factor to deny treatment to white patients.[1]

White patients who met the primary medical criteria—such as having underlying health conditions or being over a certain age—remained fully eligible for the scarce treatments and continued to receive them.[1]

Ultimately, the evidence shows that while race was explicitly listed as one of many risk factors during a temporary triage protocol, the claim that white Americans were categorically sent to the "back of the line" or denied care is a significant exaggeration of the facts.[1][4]